A Serologic Test to Diagnose Pneumocystis Pneumonia: Are We There Yet?

Serum (1->3)- -D-Glucan Levels in Primary Infection and Pulmonary Colonization with Pneumocystis jirovecii

(2011) C. Damiani et al.   JOURNAL OF CLINICAL MICROBIOLOGY

AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study

(2010) Kate Buchacz et al.   AIDS

Pneumocystis jiroveciiinfection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility

(2010) Malcolm A. Finkelman   CRITICAL REVIEWS IN MICROBIOLOGY

β-d-Glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative Patients: A prospective study

(2010) Mark G.J. de Boer et al.   JOURNAL OF INFECTION

Serum (1→3) β‐d‐Glucan as a Noninvasive Adjunct Marker for the Diagnosis ofPneumocystisPneumonia in Patients with AIDS

(2009) Tamayo Watanabe et al.   CLINICAL INFECTIOUS DISEASES

β-glucan recognition by the innate immune system

(2009) Helen S. Goodridge et al.   IMMUNOLOGICAL REVIEWS

Clinical Utility of Serum β-D-Glucan and KL-6 Levels in Pneumocystis jirovecii Pneumonia

(2009) Hideta Nakamura et al.   INTERNAL MEDICINE

Serum (1-3)- -D-Glucan as a Tool for Diagnosis of Pneumocystis jirovecii Pneumonia in Patients with Human Immunodeficiency Virus Infection or Hematological Malignancy

(2009) S. Desmet et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial

(2009) Andrew R. Zolopa et al.   PLoS One

S-Adenosylmethionine Levels in the Diagnosis of Pneumocystis carinii Pneumonia in Patients with HIV Infection

(2008) M. J. Skelly et al.   CLINICAL INFECTIOUS DISEASES